関連する実験動画
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
まとめ
この研究では,DNAase Iが核内の対極のDNA鎖を切断する間の転移を決定しました. 結果は,既存のヌクレオソームモデルと一致しない段階的な削減を明らかにし,ターミナルの特定の衰退を示しています.
科学分野:
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
- 遺伝学 遺伝学とは
背景:
- 核酸はDNAを分割しますが,対極の鎖切断の間の散歩は不明です.
- DNAase Iは,単一鎖の原子核のDNAを定期的な間隔で切断する.
研究 の 目的:
- 核DNAのDNAアゼIによって作られる対極の鎖切断の間の転移を決定する.
- DNAアゼI分裂パターンに基づく核細胞内のDNA折り畳みモデルを調査する.
主な方法:
- DNAase IによるDNA消化に続いて,ゲル電泳法が行われます.
- 高復元ゲル法を使用してDNA断片の分離.
- 単一鎖特異的な核酵素とDNAポリメラーゼを用いた構造分析.
主要な成果:
- DNAase Iは,単一鎖の尾を持つ二重鎖のDNA断片を生成する.
- 断片は,3'-OH端末 (8核酸) と,推論された5'-P端末 (2または12核酸) が収縮している.
- 反対の糸切断の間の散歩は (10-n + 8) と (10-n + 2) の塩基対である.
結論:
- DNAase Iは,段階的な切断でDNAを生成し,既存の核分裂体モデルと矛盾する.
- モデルには改訂が必要になる可能性があり,DNAase I認識と核細胞DNAの分裂部位の違いを示唆している.
関連する概念動画
01:27Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
01:29Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
01:29Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
01:27Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K